| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |